National Health Investors NHI Private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4
Private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss.
The official record: National Health Investors’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about National Health Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is National Health Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4?
- National Health Investors (NHI) reported private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 of $205.95M in Q1 2026.
- How has National Health Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 changed year-over-year?
- National Health Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 decreased by 20.7% year-over-year, from $259.77M to $205.95M.
- What is the long-term trend for National Health Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4?
- Over 3 years (2022 to 2025), National Health Investors's private debt held-for-investment, at amortized cost, net of valuation allowance – $3 and $4 has grown at a -4.5% compound annual growth rate (CAGR), from $233.14M to $203.3M.